|
CCT6P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.579400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.503600E-02 |
| Normal-vs-Stage2 |
1.981760E-02 |
| Normal-vs-Stage3 |
1.113600E-02 |
| Normal-vs-Stage4 |
4.607900E-02 |
| Stage1-vs-Stage2 |
3.264400E-01 |
| Stage1-vs-Stage3 |
3.672200E-01 |
| Stage1-vs-Stage4 |
5.713400E-01 |
| Stage2-vs-Stage3 |
7.784200E-01 |
| Stage2-vs-Stage4 |
7.659200E-01 |
| Stage3-vs-Stage4 |
9.287200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.619600E-03 |
| Normal-vs-AfricanAmerican |
2.199600E-01 |
| Normal-vs-Asian |
3.385200E-01 |
| Caucasian-vs-AfricanAmerican |
7.677200E-01 |
| Caucasian-vs-Asian |
3.146000E-01 |
| AfricanAmerican-vs-Asian |
6.950200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.320040E-01 |
| Normal-vs-Female |
6.482800E-03 |
| Male-vs-Female |
1.226000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.196400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.832000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.311560E-02 |
| Normal-vs-Age(81-100Yrs) |
2.717700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.933600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.555800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.920000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.671000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.548610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.239200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.291900E-02 |
| Classical-VS-Follicular |
7.662400E-02 |
| Classical-VS-Other |
3.012000E-01 |
| Classical-VS-Normal |
8.333900E-02 |
| Tall-VS-Follicular |
5.108400E-01 |
| Tall-VS-Other |
1.312050E-01 |
| Tall-VS-Normal |
2.055700E-03 |
| Follicular-VS-Other |
6.182100E-02 |
| Follicular-VS-Normal |
6.419100E-03 |
| Other-VS-Normal |
5.477600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.236600E-03 |
| Normal-vs-N1 |
2.959600E-01 |
| N0-vs-N1 |
3.884800E-01 |
|
|
